Table 1
Baseline characteristics | Overall (n = 55) | SVR (n = 28) | no SVR (n = 27) | p | AOR | 95% CI | p |
|---|---|---|---|---|---|---|---|
Age (years; SD) | 43; 3.9 | 42; 4.3 | 44; 3.2 | 0.072 | 0.948 | 0.798–1.127 | 0.546 |
Sex (male) | 46 (84%) | 23 (82%) | 23 (85%) | 0.763 | Â | Â | Â |
Patients on HAART | 49 (89%) | 24 (85%) | 25 (92%) | 0.421 | Â | Â | Â |
Baseline CD4 cells/μL; SD | 540; 298 | 536; 228 | 540; 356 | 0.184 |  |  |  |
HIV-RNA cp/mL | <50 | <50 | <50 | Â | Â | Â | Â |
HCV genotype | Â | Â | Â | Â | Â | Â | Â |
1 | 21 (38%) | 6 (21%) | 15 (56%) | reference | reference | reference | reference |
not 1 | 34 (62%) | 22 (79%) | 12 (44%) | 0.019 | 5.457 | 1.256–23.721 | 0.024 |
HCV viremia (Log IU/mL); SD | 5.87; 0.7 | 5.67; 0.8 | 5.96; 0.5 | 0.102 | Â | Â | Â |
ALT (IU/L); SD | 100; 60 | 104; 62 | 90; 57 | 0.261 | Â | Â | Â |
BMI; SD | 23.4; 2.2 | 23.6; 2 | 22.8; 3.2 | 0.460 | Â | Â | Â |
Hyperglicemia or diabetes | 19 (34%) | 4 (14%) | 15 (55%) | 0.001 | 0.113 | 0.024–0.528 | 0.006 |
Cholesterol >200 mg/dL | 10 (18%) | 8 (28%) | 2 (7%) | 0.078 | 8.373 | 1.125–62.316 | 0.038 |
LDL >100 mg/dL | 15 (27%) | 10 (36%) | 5 (18%) | 0.062 | Â | Â | Â |
Lipoatrophy | 29 (53%) | 13 (46%) | 16 (59%) | 0.455 | Â | Â | Â |